Investor Relations Director

Tyvan LLC

22h•Onsite

About The Position

The Director of Investor Relations is Nutex Health’s day-to-day voice to Wall Street and primary point of contact for the investment community. The role owns relationships with current and prospective shareholders, sell-side analysts, and institutional investors, and is accountable for how NUTX is understood, followed, and valued in the market. The Director must have deep knowledge of Nutex’s financial statements, operating model, payer dynamics, and growth strategy, and represent the Company credibly in investor meetings, conference calls, and roadshows when the CEO and CFO are unavailable. Within the Company’s disclosure policy, the Director is an authorized spokesperson to the financial community. The Director leads investor relationships and communications; develops and delivers the Company’s investment thesis; manages the quarterly earnings process and related financial communications; and develops investor targeting, roadshows, conference participation, and institutional growth. The role also monitors market intelligence, reports to executive leadership and the Board, and ensures compliance with applicable disclosure, securities, and listing requirements. The position manages IR vendors and the IR budget. This is an office-based role in Houston with frequent domestic travel. Availability outside normal business hours is required around earnings releases, conferences, and material announcements. The Director is designated an insider subject to the Company’s Securities Trading Policy, including blackout periods.

Requirements

Bachelor’s degree in Finance, Accounting, Economics, or Business required.
At least 8 years of combined experience in investor relations, equity research, investment banking, buy-side investing, or corporate finance, including at least 3–5 years in a public-company IR role.
Demonstrated record of independently leading investor meetings, earnings calls, and roadshows.
Expert command of GAAP and non-GAAP financial statements, valuation methods, and financial modeling.
Working knowledge of Regulation FD, SEC reporting, and Nasdaq requirements.
Polished, confident public speaker able to handle challenging investor questions with composure.
Exceptional written communication skills for scripts, press releases, and presentations.
Sound judgment and discretion with material non-public information.
Proficiency with Microsoft Office, investor CRM platforms, and market data tools such as Bloomberg, FactSet, or S&P Capital IQ.
Availability outside normal business hours around earnings releases, conferences, and material announcements.
Ability to travel frequently domestically.

Nice To Haves

MBA, CFA, or CPA strongly preferred; NIRI Investor Relations Charter (IRC) is a plus.
Established relationships with institutional investors and sell-side analysts, ideally in healthcare services, hospitals, or small/mid-cap growth companies.
Experience increasing institutional ownership or analyst coverage strongly preferred.
Understanding of healthcare reimbursement, payer mix, and hospital operations strongly preferred.

Responsibilities

Own and manage relationships with current shareholders, including institutional, retail, and insider holders, and serve as the single point of contact for investor inquiries.
Lead investor calls and one-on-one meetings with current and prospective investors; independently represent NUTX when the CEO and CFO are unavailable.
Maintain an investor CRM documenting interactions, open questions, and follow-ups, and ensure timely, consistent responses.
Monitor the shareholder register, ownership changes, and trading activity, and brief executive leadership on changes in the shareholder base and market sentiment.
Gather and report investor and analyst feedback to the CEO, CFO, and Board, including perception studies as appropriate.
Serve as an authorized Company spokesperson to the investment community in compliance with Regulation FD and Company policies.
Develop, refine, and consistently communicate the NUTX investment thesis, including the hospital model, payer mix, growth pipeline, capital allocation, and competitive positioning.
Translate financial and operational results into clear messaging for analysts, portfolio managers, and the broader market.
Prepare executives for investor interactions with briefing books, talking points, investor profiles, and anticipated questions and answers.
Own the quarterly earnings process, including the calendar, earnings press release, call script, slide presentation, Q&A preparation, call logistics, and post-call investor follow-up.
Partner with Finance, Accounting, and Legal to ensure accuracy and consistency across earnings materials, SEC filings, proxy statements, and the annual report.
Understand and explain financial statements, revenue drivers, reimbursement, Adjusted EBITDA reconciliations, cash flow, balance sheet, and non-GAAP measures.
Support the CFO in developing and communicating financial guidance, and track consensus estimates against Company expectations.
Maintain the investor relations section of the Company website, including presentations, press releases, SEC filings, and event materials.
Develop and execute a targeting strategy to broaden and diversify the shareholder base, with a specific goal of increasing institutional ownership.
Plan and lead non-deal roadshows, reverse roadshows, facility tours, and an Investor Day as appropriate.
Secure invitations to and manage NUTX participation at healthcare and small/mid-cap investor conferences, including scheduling one-on-one and group meetings.
Build relationships with sell-side analysts to maintain and expand research coverage, and review analyst models and reports for factual accuracy.
Support equity, debt, and strategic transactions in partnership with the CFO and outside advisors.
Monitor peer hospital and healthcare services companies for valuation, performance, and messaging, and benchmark NUTX against peers.
Track analyst reports, short interest, trading activity, and industry and regulatory developments affecting investor perception.
Prepare investor relations updates for executive leadership and the Board, including shareholder trends and outreach results.
Ensure investor communications comply with Regulation FD, SEC rules, Nasdaq listing requirements, quiet-period practices, and Company policy.
Partner with Legal on disclosure controls, safe-harbor language, and approval workflows for public communications.
Support the annual shareholder meeting and shareholder engagement on governance matters.
Manage relationships with the IR website provider, newswire, transfer agent, and outside IR or shareholder-intelligence firms, and own the IR budget.